For the past three years, much of the product security efforts have centered on FMD, MDR and DSCSA compliance ahead of the regulatory deadlines. With the FMD deadline behind us now, and 2023 rapidly approaching, the industry must look beyond compliance and assess where serialisation and traceability can fit into a broader product security strategy.
This workshop focuses on identifying and maximising the value beyond compliance in your serialisation and traceability systems. With discussions centering around analytical outcomes and the utilisation of data collected, this workshop is designed to help you build on your regulatory traceability compliance and develop a holistic brand protection strategy.
In this workshop, you will:
· Discuss the global serialisation and traceability requirements to identify similarities and differences in approach, with reference to both drug and medical device supply
· Examine the outcomes generated from traceability compliance: How can we look to utilise these systems for additional product and supply chains securitisation?
· Analyse where FMD, MDR and DSCSA compliance fit into a broader product and supply chain protection strategy, and where further development is needed
· Identify areas of further investment or opportunity: Mapping the value in future product protection and supply chain securitisation to ensure viable ROI